New study tests smarter ways to start opioid treatment in the ER

NCT ID NCT06793696

Completed Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested different strategies to help emergency doctors start buprenorphine treatment for people with opioid use disorder. Researchers used a computer system to prompt nurses and doctors, and gave patients educational materials. The goal was to see which combination of tools works best to increase treatment rates. Over 1,100 patients took part, and the results will guide future larger studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: clinical decision support system
What this could lead to: If successful, this could point toward better ways to help emergency doctors start medication for opioid addiction, potentially saving lives.
What could go wrong: This is an early optimization study, not a final test. The results may not lead to improved patient outcomes, and the tools may not work in all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICAL DECISION SUPPORT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLINICAL DECISION SUPPORT OPIOID-USE DISORDER

Contacts and locations

Locations

Yale New Haven Hospital

New Haven, Connecticut, 06510, United States
Yale New Haven Hospital- St. Raphael

New Haven, Connecticut, 06510, United States
Yale New Haven Shoreline Medical Center

Guilford, Connecticut, 06437, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.